Zoetis Inc. said late Monday it will buy Pharmaq, a fish vaccine company, from investment firm Permira for $765 million. Pharmaq generated revenues of about $80 million in 2014 and has 200 employees. The deal is expected to boost Zoetis’ livestock business with leading vaccines and drugs for farmed fish and provide access to late-stage pipeline of new drug candidates. Shares of Zoetis were unchanged in after-hours trading.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News

